PHD.L Regulatory News (PHD)

PROACTIS Holdings PLC

Trading Update and

Acquisition of Esize Holdings BV

PROACTIS Holdings PLC ("PROACTIS", the "Group" or the "Company"), the global spend management and B2B eCommerce solution provider reports a preliminary update on trading for the financial year ended 31 July 2018 and announces that it has entered into an agreement to acquire the entire issued share capital of Esize Holdings BV ("Esize"), a Netherlands based procurement software business for buy side organisations for a maximum consideration of up to €15.2 million (the "Acquisition").

Trading Update

PROACTIS' expects to report revenue1 of approximately £52 million and Adjusted EBITDA1 of approximately £17 million for the year ended 31 July 2018. Further, deal intake was strong with 64 new names with a total initial contract value of £8.7m (2017: 54; £4.1m) and 119 (2017: 110) upsell deals.

Net debt2 as at 31 July 2018 is expected to be approximately £30 million.

The Company is in the process of closing out its year-end and expects to provide a more detailed trading update on 22 August 2018.

1 Revenue and Adjusted EBITDA are both unaudited and Adjusted EBITDA is stated before the Company's assessment of non-recurring administrative expenses, amortisation of customer related intangible assets and share based payment charges.

2 Net debt is unaudited and is calculated excluding the $5 million 2.0 per cent. convertible unsecured loan notes due 2022 and convertible at £1.65 per share. These loan notes were issued as part consideration in connection with the acquisition of Perfect Commerce, LLC on 4 August 2017

Acquisition of Esize

Esize is a recognised territory leader in the Netherlands for its cloud-based spend management solutions. Its solutions cover the full procurement cycle for indirect spend and provide PROACTIS with additional capabilities in the travel and expense management and contract labour markets. These are two markets which are adjacent to, and of an equivalent size to, PROACTIS' core indirect product procurement proposition. The Board believes that they will become increasingly important to mid-market buyside customers going forward. It has approximately 60 customers across the private and public sectors and approximately 50 employees.

Esize has a SaaS based business model, which is consistent with PROACTIS', and which delivers high levels of contracted annual recurring revenue with high retention rates. Esize's recent growth rates have been above 10% per annum and it has historically delivered comparable profitability margins to PROACTIS.

The acquisition will also benefit PROACTIS by creating a scaled operation in The Netherlands, where it will consolidate its existing operations. It will also allow PROACTIS to access growth opportunities through the cross-selling of complementary capabilities to both customer bases.

The Board expects this Acquisition to be immediately earnings enhancing.

For the year ended to 31 December 2017, Esize reported revenue of €5.1 million (c.19% YOY growth), €1.7 million of EBITDA (c.14% YOY growth) and a profit before tax of €0.6 million (c.48% YOY growth). 

Terms of the Acquisition

The maximum consideration payable for the Acquisition (subject to minor working capital adjustments) is €15.2 million. This comprises an initial consideration of €14.2 million (the "Initial Consideration") and a deferred contingent consideration of between €0.5 million and €1.0 million based on achieving certain revenue targets for the year ending 31 July 2019 (the "Deferred Consideration").

The Initial Consideration will be satisfied by:

(i) €9.6 million in cash, to be satisfied from the Group's existing cash resources and a draw down from the Group's extended £35 million (previously £30 million) revolving credit bank facility;

(ii) 1,292,491 ordinary shares of 10 pence each in the Company (the "Ordinary Shares") (being €2.4 million at an issue price of £1.65 pence per Ordinary Share, which is equivalent to €1.6 million at the closing mid-market share price on 6 August 2018); and

(iii) €3.0 million by way of a convertible loan note (see below).

The Deferred Consideration will be satisfied by way of a convertible loan note of between €0.5 million and €1.0 million which is convertible on or after 1 November 2019. The amount of Deferred Consideration payable will be calculated on a sliding scale based on Esize achieving revenues between €5.5 million and €6.0 million for the year ending 31 July 2019.

All consideration payable in Ordinary Shares will be issued under the Company's existing authorities and will be subject to a one-year lock in agreement and a further one year orderly market agreement, from the date of admission of the Ordinary Shares.

The number of Ordinary Shares to be issued in respect of the Initial Consideration and the Deferred Consideration is calculated by dividing the appropriate consideration values by reference to:

(i) In respect of the Initial Consideration, 1.1254 EUR/GBP and then by dividing by the negotiated issue price of £1.65 per Ordinary Share; and

(ii) In respect of the Deferred Consideration, 1.1254 EUR/GBP and then by dividing by the negotiated conversion price of £1.75 per Ordinary Share.

Issue of Equity and Total Voting Rights

Pursuant to the Initial Consideration, application has been made for the 1,292,491 new Ordinary Shares to be admitted to trading on AIM ("Admission") and dealings are expected to commence on 13 August 2018. The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares.

The total number of Ordinary Shares in issue following Admission will be 94,528,614. Accordingly, the figure of 94,528,614 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Hamp Wall, CEO of PROACTIS commented:

"I am encouraged by the expected out turn for the year, particularly with regard to underlying growth driven by the rate and value of new deal intake and upselling activity which are key indicators of the relevance of our solutions and our ability to sell. I am optimistic that this will continue for the foreseeable future and that we are confident of returning to normalised levels of growth and churn into FY2019.

"Acquisitions are a key part of our Group's growth strategy and Esize perfectly satisfies our acquisition criteria. We are excited by this growing, profitable and cash generative business that brings with it a scaled operation in a key new North West European geography, a SaaS/cloud-based business model delivering security over forward revenues and an additive technology stack.

"In addition, Esize has a strong management team which we look forward to welcoming into the Group. As well as the immediate benefits, we believe there will be significant cross sell opportunities across both customer bases on the buy side as well as, in the longer term, the extension into the supply side networking opportunity."

Tim Schaefers, CEO of Esize commented:

"By combining our efforts, we will be in an even better position to serve our customers, which increasingly demand global support. The combination will give Esize the opportunity to add new products and services to our existing portfolio. This will give our customers even more options which may drive further growth. As the board and shareholders, we therefore see that as a win-win situation."

This announcement contains inside information for the purposes of article 7 of Regulation 596/2014

For further information, please contact:

Notes to Editors:

PROACTIS creates, sells and maintains software and services which enable organisations to streamline, control and monitor all indirect expenditure. Its solutions are used in approximately 1,000 buying organisations around the world from the commercial, public and not-for-profit sectors.

PROACTIS is head quartered in London and floated on the AIM market of the London Stock Exchange in June 2006.